Pharmacolog appoints new CFO
Pharmacolog publishes annual report for 2022
Pharmacolog: Interim report January – March 2023
The board of Pharmacolog resolves, subject to the approval of an extraordinary general meeting on a rights issue of units of approximately SEK 27.3 million
Pharmacolog implements changes in board and management
Pharmacolog’s chairman of the board leaves his position at his own request
New strategic direction for Pharmacolog
Pharmacolog implements change in management team – dismisses CEO
Pharmacolog’s Year-end Bulletin 2022
Pharmacolog receives largest order to date – a strong start to 2023
The website uses necessary cookies to ensure the website functions properly. You can also choose to consent to cookies for statistical purposes.
Search
By requesting this documentation I agree to the terms in Pharmacologs privacy policy
